Investors & Media

test

Tempest and Millendo have announced a merger.

 

Corporate Profile

Millendo Therapeutics is a biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases. We create distinct and transformative treatments for endocrine diseases where there is a significant unmet medical need.  

Corporate Presentation

More information is coming soon.

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.